Publications
P302
Inorg. Chem., 2025, 64, 16192-16203.
Synthesis and Biological Evaluation of Itraconazole Derivatives: Design in an Old Scaffold.
P300
RSC Med. Chem. 2025, 16, 3746–3763.
Pharmacophore-guided optimization of the hit compound CTN1122 in the design of promising imidazo[1,2-a]pyrazine derivatives targeting the casein kinase 1 for antileishmanial therapy
P290
ChemMedChem. 2025, 20, e202400862.
Investigating the C2 modulation of the imidazo[1,2-a]pyrazine-based hit compound CTN1122: synthesis, in vitro antileishmanial activity, cytotoxicity and casein kinase 1 inhibition.
P285
Int. J. Pharm. Res. Al. Sci. 2024, 13, 1-11.
Design and synthesis of functionalized 2,4-diamino-1,3,5-triazines, potential inhibitors involved in immune and inflammatory response.
P241
Int. J. Mol. Sci. 2021, 22, 7763.
Exosomes as New Biomarkers and Drug Delivery Tools for the Prevention and Treatment of Various Diseases: Current Perspectives.
doi: 10.3390/ijms22157763
P240
Molecules 2021, 26, 6572.
Dibenzofuran derivatives inspired from cercosporamide as dual inhibitors of Pim and CLK1 kinases.
doi: 10.3390/molecules26216572
P233
Drug Discov. Today. 2021, 26, 56-68.
Tetraspanins: useful multifunction proteins for the possible design and development of small-molecule therapeutic tools.
doi: 10.1016/j.drudis.2020.10.022
P212
Eur. J. Med. Chem. 2020, 189, 112082.
New Azole Antifungals with a Fused Triazinone Scaffold.
doi: 10.1016/j.ejmech.2020.112082
P201
Lipids Health Dis. 2019, 18, 168.
4-cholesten-3-one decreases breast cancer cell viability and alters membrane raft-localized EGFR expression by reducing lipogenesis and enhancing LXR-dependent cholesterol transporters.
doi: 10.1186/s12944-019-1103-7
P178
Eur. J. Med. Chem. 2018, 154, 101-109.
Structure-based design of novel quinoxaline-2-carboxylic acids and analogues as Pim-1 inhibitors.
doi: 10.1016/j.ejmech.2018.04.056
P154
Sci. Rep. 2016, 6, 21088;
Activation of EGFR by small compounds through coupling the generation of hydrogen peroxide to stable dimerization of Cu/Zn SOD1.
doi:10.1038/srep21088.
P146
Med. Mycol. 2016, 54, 764-775.
The amino acid substitution N136Y in Candida albicans sterol 14alpha-demethylase is involved in fluconazole resistance.
doi: 10.1093/mmy/myw023
P142
Eur. J. Med. Chem. 2015, 105, 80-105.
Development of new highly potent imidazo[1,2-b]pyridazines targeting Toxoplasma gondii Calcium-Dependent Protein Kinase 1.
doi: 10.1016/j.ejmech.2015.10.004
P139
Eur. J. Med. Chem. 2015, 92, 124-134.
Synthesis and molecular modelling studies of 8-arylpyrido[3',2':4,5]thieno[3,2-d]pyrimidin-4-amines as multitarget Ser/Thr kinases inhibitors.
doi: 10.1016/j.ejmech.2014.12.038
P131
Bioorg. Med. Chem. Lett. 2014, 24, 5037-5040.
Synthesis of new pyridazino[4,5-b]indol-4-ones and pyridazin-3(2H)-one analogs as DYRK1A inhibitors.
P127
Bioorg. Med. Chem. Lett. 2014, 24, 3748-3752.
Discovery of (7-aryl-1,5-naphthyridin-2-yl)ureas as dual inhibitors of ERK2 and Aurora B kinases with antiproliferative activity against cancer cells.
P126
Sci. Rep. 2014, 4:3977.
Screening and discovery of nitro-benzoxadiazole compounds activating epidermal growth factor receptor (EGFR) in cancer cells.
doi: 10.1038/srep03977.
P116
Tetrahedron, 2013, 69, 3182-3191.
Novel synthesis of angular thiazolo[5,4-f] and [4,5-h]quinazolines, preparation of their linear thiazolo[4,5-g] and [5,4-g]quinazoline analogs.
P114
ACS Med. Chem. Lett., 2013, 4, 288-292.
Discovery of a novel broad-spectrum antifungal agent, derived from albaconazole.
PXXX
Org. Biomol. Chem. 2012, 10, 4916-4925
Study of N(1)-alkylation of indoles from the reaction of 2(or 3)-aminoindole-3-(or 2)carbonitriles with DMF-dialkylacetals
Autres publications scientifiques
PS22
Molbank, 2023
Potassium 6-oxo-7,13,16,22-tetraazatetracyclo[12.6.2.18,12.017,21]tricosa-1(20),8(23), 9,11,14,16,18,21-octaen-2-yne-15-carboxylate.
PS02
Marine Drugs. 2021, 378.
Untargeted metabolomics approach for the discovery of environment-related pyran-2-ones chemodiversity in a marine-sourced Penicillium restrictum.
PS01
Molecules. 2021, 26,867
New quinoxaline derivatives as dual Pim-1/2 inhibitors: design, synthesis and biological evaluation.
Brevets
B17.
Novel fused pyrimidone and triazinone derivatives containing bridged nitrogen, their process of preparation and their therapeutic uses as antifungal and/or antiparasitic agents.
PCT WO 2017/021178 A1, 9 février 2017.